YERVOY | 合法醫療器材資訊網
YERVOYisindicatedfortheadjuvanttreatmentofpatientswithcutaneousmelanomawithpathologicinvolvementofregionallymphnodesofmorethan1mmwho ...
YERVOY is indicated for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who ...
YERVOY package insert Nivolumab package insert 2021 Ipilimumab package insert 2020 Ipilimumab (Yervoy) Pembrolizumab package insert Ipilimumab FDA Yervoy Nivolumab INDICATIONS Drug FDA Pembrolizumab label KEYTRUDA FDA Nivolumab HCC dose FDA Data Atezolizumab FDA Nivolumab small cell lung cancer FDA approval search Pembrolizumab package insert Nivolumab package insert 2021 Atezolizumab package insert 2020 YERVOY package insert Keytruda Merck Axitinib package insert 2020 keytruda健保 Ipilimumab package insert 2020 Ipilimumab (Yervoy) Ipilimumab FDA Yervoy Nivolumab INDICATIONS 醫療器材滅菌 MBL FLUORO HEPANA TEST 台南市新化區竹子腳235之61號 瑞安科技 台灣 水壺 工廠 保溫瓶工廠 台灣保溫杯工廠 立 忠實 業 股份有限公司 702 安南區
Yervoy | 合法醫療器材資訊網
Adjuvant Treatment of Melanoma: YERVOY 10 mg/kg every 3 weeks for 4 doses, ... (Drug Rash with Eosinophilia and Systemic Symptoms). Read More
ipilimumab - YERVOY | 合法醫療器材資訊網
YERVOY is indicated for the treatment of unresectable or metastatic melanoma [see Clinical. Studies (14.1)]. 1.2. Adjuvant Treatment of Melanoma. YERVOY is ... Read More
YERVOY (ipilimumab) | 合法醫療器材資訊網
YERVOY, in combination with nivolumab, is indicated for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose ... Read More
YERVOY (ipilimumab) | 合法醫療器材資訊網
YERVOY is indicated for the treatment of unresectable or metastatic melanoma in adults and pediatric patients 12 years and older. 1.2. Adjuvant Treatment of ... Read More
YERVOY | 合法醫療器材資訊網
YERVOY is indicated for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who ... Read More
YERVOY®(ipilimumab) | 合法醫療器材資訊網
YERVOY® (ipilimumab) is a prescription medicine used in adults and children 12 years of age and older to treat melanoma (a kind of skin cancer) that has ... Read More
Gateway for Healthcare Professionals | 合法醫療器材資訊網
YERVOY® (ipilimumab) is indicated for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more ... Read More
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS | 合法醫療器材資訊網
2011年7月13日 — YERVOY in combination with nivolumab is indicated for the treatment ... The printed package leaflet of the medicinal product must state the ... Read More
相關資訊整理
【"羅氏" 凡塔那PD-L1 (SP142) 單株抗體 (未滅菌)】許可證字號:衛部醫器輸壹字第017939號
器材品名:"羅氏"凡塔那PD-L1(SP142)單株抗體(未滅菌)許可證字號:衛部醫器輸壹字第017939號註銷狀態:註銷日期:註銷理由:有效...